Levator Syndrome Treatments — CPB 0679 | AETNA Coverage Update

Aetna modified CPB 0679 for levator syndrome treatments, effective October 17, 2025. Here's what billing teams need to know about covered codes, hard session limits, and the growing list of excluded interventions.

Aetna, a CVS Health company, updated its levator syndrome coverage policy under CPB 0679 Aetna system, affecting CPT codes 97014 and 97032 for electrical stimulation and HCPCS code E0746 for biofeedback. The policy sets strict medical necessity criteria for high-voltage pulsed electro-galvanic stimulation and biofeedback while explicitly classifying botulinum toxin injections, sacral nerve stimulation, and pudendal nerve injections as experimental. If your team bills for any pelvic floor or anorectal pain treatment, this coverage policy deserves a close read before October 17, 2025.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna
Policy	Levator Syndrome Treatments
Policy Code	CPB 0679
Change Type	Modified
Effective Date	October 17, 2025
Impact Level	Medium
Specialties Affected	Colorectal surgery, gastroenterology, urology, pelvic floor physical therapy, pain management
Key Action	Audit charge capture for CPT 97014, 97032, and HCPCS E0746 — confirm all three medical necessity criteria are documented before billing

---

Aetna Levator Syndrome Coverage Criteria and Medical Necessity Requirements 2025

Aetna covers high-voltage pulsed electro-galvanic stimulation for levator syndrome under two CPT codes: 97014 (electrical stimulation, unattended) and 97032 (electrical stimulation, manual, each 15 minutes). Medical necessity requires meeting all three of the following criteria — not one, not two, all three.

First, no neurological cause for the pain can be detected. Second, the member must have failed conservative treatments. That list includes high-fiber diet, withdrawal of constipating drugs (calcium channel blockers, narcotics) or drugs that cause diarrhea (antibiotics, quinidine, theophylline), perineal strengthening exercises, rectal massage, warm baths, and drug therapy including muscle relaxants, non-narcotic analgesics, and sedatives.

Third, no underlying disease has been found through anorectal examination, manometry, radiology, or endoscopy. All three boxes must be checked in the medical record before you bill CPT 97014 or 97032.

The session cap is real and it's a hard stop. Aetna does not consider more than three 60-minute sessions administered over a 10-day period medically necessary. Bill beyond that limit and you're looking at a claim denial. Document the session count and dates in your charge capture from day one.

Biofeedback (HCPCS E0746) is also covered when the same three criteria above are met. Aetna cross-references CPB 0132 for biofeedback-specific billing guidelines. If you bill biofeedback for this indication, pull CPB 0132 and confirm your documentation satisfies both policies.

Home-use electro-galvanic stimulators are excluded. Aetna classifies them as experimental and investigational. Don't bill HCPCS E0745 expecting reimbursement under this policy — it won't come.

The diagnosis codes that drive this coverage policy are K59.4 (anal spasm / proctalgia fugax) and K62.89 (other specified diseases of anus and rectum, which covers chronic anal pain syndrome and levator syndrome). Make sure your ICD-10 coding is precise. A mismatched diagnosis code is a fast path to a claim denial, even when the clinical picture is clear.

The policy doesn't list specific prior authorization requirements in the text, but given the three-part medical necessity criteria and the session cap, you should verify prior auth requirements with the specific Aetna plan before the first treatment session. Many Aetna commercial plans apply utilization management to physical medicine codes like 97032. Don't assume PA isn't required.

---

Aetna Levator Syndrome Exclusions and Non-Covered Indications

This is where the policy gets expensive for practices offering newer or injection-based treatments. Aetna explicitly classifies five interventions as experimental, investigational, or unproven for levator syndrome:

The real issue here is that several of these — botulinum toxin and sacral nerve stimulation especially — are used in practice and may have payer coverage for other indications. If your facility bills these codes for multiple conditions, your billing team needs to confirm the diagnosis code pairing on every claim. A botulinum toxin injection billed under K59.4 will deny. The same injection billed under a covered indication for another Aetna policy may pay. Mixing up the diagnosis linkage is an easy error with a hard financial consequence.

---

Coverage Indications at a Glance

---

Aetna Levator Syndrome Billing Guidelines and Action Items 2025

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Levator Syndrome Under CPB 0679

Covered CPT Codes (When Selection Criteria Are Met)

Code	Type	Description Copy
97014	CPT	Application of a modality to one or more areas; electrical stimulation (unattended)
97032	CPT	Application of a modality to one or more areas; electrical stimulation (manual), each 15 minutes

Covered HCPCS Codes (When Selection Criteria Are Met)

Code	Type	Description Copy
E0746	HCPCS	Electromyography (EMG), biofeedback device

Other CPT Codes Related to CPB 0679 (Not Covered for This Indication Unless Otherwise Noted)

Not Covered / Experimental HCPCS Codes

Key ICD-10-CM Diagnosis Codes

Code	Description Copy
K59.4	Anal spasm [proctalgia fugax]
K62.89	Other specified diseases of anus and rectum [chronic anal pain syndrome, levator syndrome]

---